291 related articles for article (PubMed ID: 35249158)
1. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
4. Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.
Yang L; Fu M; Yu L; Wang H; Chen X; Sun H
Front Endocrinol (Lausanne); 2024; 15():1293842. PubMed ID: 38370351
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous computed tomography-guided core needle biopsy can be used to histologically confirm the clinical features and long-term prognosis of pulmonary neuroendocrine neoplasms.
Chen C; Wang Y; Huang H; He X; Li W
Jpn J Radiol; 2023 Dec; 41(12):1414-1419. PubMed ID: 37395983
[TBL] [Abstract][Full Text] [Related]
7. Analysis on the characteristics and prognosis of pulmonary neuroendocrine tumors.
Wu BS; Hu Y; Sun J; Wang JL; Wang P; Dong WW; Tao HT; Gao WJ
Asian Pac J Cancer Prev; 2014; 15(5):2205-10. PubMed ID: 24716958
[TBL] [Abstract][Full Text] [Related]
8. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).
Saber M; Ismail Y; Alieldin N; Loay I; El Zawahry M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):151-158. PubMed ID: 30470605
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
12. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
Iyoda A; Azuma Y; Sano A
Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
[TBL] [Abstract][Full Text] [Related]
14. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.
Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F
Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.
Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N
Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
Travis WD; Linnoila RI; Tsokos MG; Hitchcock CL; Cutler GB; Nieman L; Chrousos G; Pass H; Doppman J
Am J Surg Pathol; 1991 Jun; 15(6):529-53. PubMed ID: 1709558
[TBL] [Abstract][Full Text] [Related]
18. [Progress of Immune Checkpoint Inhibitors
in the Treatment of Advanced Pulmonary Neuroendocrine Tumors].
Chen H; Meng Q
Zhongguo Fei Ai Za Zhi; 2021 Nov; 24(11):784-789. PubMed ID: 34802210
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
[TBL] [Abstract][Full Text] [Related]
20. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
